Physician profile
Raymond E Miller
NPI 1205802188
$8,697.04
in general payments reported to CMS, 2019-2025
21 companies · $862 in 2025
The $862 reported for 2025 was less than what a typical Clinical Cardiac Electrophysiology provider received nationally (typical 2025 total: $2,477).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,736 · 2020: $549 · 2021: $776 · 2022: $892 · 2023: $949 · 2024: $933 · 2025: $862.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,717 · Debt Forgiveness: $27.11.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,717.36 |
| Debt Forgiveness | $27.11 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic Vascular, INC. | $3,243.84 | 2019-2020 | |
| Medtronic, INC. | $2,057.71 | 2021-2025 | Cobalt Dr Mri Surescan, Selectsecure, Micra |
| Abbott Laboratories | $1,083.78 | 2019-2025 | Gallant, Aveir, Ensite |
| Novartis Pharmaceuticals Corporation | $519.10 | 2019-2024 | |
| Boston Scientific Corporation | $387.01 | 2019-2025 | Opticross 35, Angiojet Ultra 5000a, Rotapro |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $341.37 | 2019-2025 | Lifevest |
| E.R. Squibb & Sons, L.L.C. | $323.75 | 2019-2023 | Camzyos, Eliquis |
| Astrazeneca Pharmaceuticals LP | $167.91 | 2019-2024 | Brilinta |
| Chiesi USA, INC. | $122.59 | 2021-2022 | |
| Stryker Corporation | $116.82 | 2025 | Flowtriever |
| Pfizer INC. | $62.88 | 2019 | |
| Janssen Pharmaceuticals, INC | $50.46 | 2019-2021 | |
| Amarin Pharma, INC. | $33.22 | 2019 | |
| Recor Medical INC | $32.08 | 2025 | Paradise Ultrasound Renal Denervation System |
| Biotronik INC. | $29.29 | 2025 | Acticor 7 Vr-T Dx |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Baxter Healthcare | $27.11 | 2023 | |
| Philips North America LLC | $25.88 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $21.34 | 2025 | |
| W. L. Gore & Associates, INC. | $17.54 | 2024 | Gore Cardioform Septal Occluder |
| Teleflex LLC | $16.91 | 2022 | |
| Edwards Lifesciences Corporation | $16.45 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Raymond Miller listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.